Aberrant DNA methylation and tumor suppressive activity of the EBF3 gene in gastric carcinoma

International Journal of Cancer

Volumn 130, Issue 4, 2012, Pages 817-826

  Kim, Jin ^a   Min, Sun Young ^a   Lee, Hee Eun ^a   Kim, Woo Ho ^a  

^a Seoul National University   (South Korea)

Author keywords

DNA methylation; downregulation; early B cell factor 3; stomach neoplasms; tumor suppressor genes

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; COMPLEMENTARY DNA; SMALL INTERFERING RNA; TRICHOSTATIN A;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INVASION; CANCER SURVIVAL; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; EARLY B CELL FACTOR 3 GENE; FEMALE; GENE EXPRESSION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; MIGRATION INHIBITION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; STOMACH CARCINOMA; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; STOMACH NEOPLASMS; TRANS-ACTIVATORS;

EID: 83955165958     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26038     Document Type: Article

References (27)

1. Wanajo A, Sasaki A, Nagasaki H, Shimada S, Otsubo T, Owaki S, Shimizu Y, Eishi Y, Kojima K, Nakajima Y, Kawano T, Yuasa Y, et al. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer. Gastroenterology 2008; 135: 580-90.
2. Peek RM, Jr, Blaser MJ,. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2: 28-37. (Pubitemid 37328805)
3. Kang GH, Lee S, Kim JS, Jung HY,. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest 2003; 83: 635-41. (Pubitemid 36618042)
4. Das PM, Singal R,. DNA methylation and cancer. J Clin Oncol 2004; 22: 4632-42. (Pubitemid 41185132)
5. Lo PK, Lee JS, Liang X, Han L, Mori T, Fackler MJ, Sadik H, Argani P, Pandita TK, Sukumar S,. Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer. Cancer Res 2010; 70: 6047-58.
6. Takada H, Wakabayashi N, Dohi O, Yasui K, Sakakura C, Mitsufuji S, Taniwaki M, Yoshikawa T,. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer. Cancer Genet Cytogenet 2010; 197: 16-24.
7. Liberg D, Sigvardsson M, Akerblad P,. The EBF/Olf/Collier family of transcription factors: regulators of differentiation in cells originating from all three embryonal germ layers. Mol Cell Biol 2002; 22: 8389-97. (Pubitemid 35397155)
8. Liao D,. Emerging roles of the EBF family of transcription factors in tumor suppression. Mol Cancer Res 2009; 7: 1893-901.
9. Zhao LY, Niu Y, Santiago A, Liu J, Albert SH, Robertson KD, Liao D,. An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis. Cancer Res 2006; 66: 9445-52. (Pubitemid 44623641)
10. Zardo G, Tiirikainen MI, Hong C, Misra A, Feuerstein BG, Volik S, Collins CC, Lamborn KR, Bollen A, Pinkel D, Albertson DG, Costello JF,. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat Genet 2002; 32: 453-8. (Pubitemid 35266125)
11. Bennett KL, Karpenko M, Lin MT, Claus R, Arab K, Dyckhoff G, Plinkert P, Herpel E, Smiraglia D, Plass C,. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 2008; 68: 4494-9.
12. Bennett KL, Lee W, Lamarre E, Zhang X, Seth R, Scharpf J, Hunt J, Eng C,. HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas. Genes Chromosomes Cancer 2010; 49: 319-26.
13. Lin H, Grosschedl R,. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 1995; 376: 263-7.
14. Kieslinger M, Folberth S, Dobreva G, Dorn T, Croci L, Erben R, Consalez GG, Grosschedl R,. EBF2 regulates osteoblast-dependent differentiation of osteoclasts. Dev Cell 2005; 9: 757-67. (Pubitemid 41724104)
15. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, Su X, Pui CH, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758-64. (Pubitemid 46582031)
16. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807-12.
17. Hagman J, Lukin K,. Early B-cell factor 'pioneers' the way for B-cell development. Trends Immunol 2005; 26: 455-61. (Pubitemid 41139254)
18. Garel S, Marín F, Mattéi MG, Vesque C, Vincent A, Charnay P,. Family of Ebf/Olf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system. Dev Dyn 1997; 210: 191-205. (Pubitemid 27498142)
19. Bond HM, Mesuraca M, Carbone E, Bonelli P, Agosti V, Amodio N, De Rosa G, Di Nicola M, Gianni AM, Moore MA, Hata A, Grieco M, et al. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. Blood 2004; 103: 2062-70. (Pubitemid 38326221)
20. Bennett KL, Romigh T, Eng C,. Disruption of transforming growth factor-beta signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis. Cancer Res 2009; 69: 9301-5.
21. Chakravarti N, Myers JN, Aggarwal BB,. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int J Cancer 2006; 119: 1268-75. (Pubitemid 44258799)
22. Sato K, Tamura G, Tsuchiya T, Endoh Y, Sakata K, Motoyama T, Usuba O, Kimura W, Terashima M, Nishizuka S, Zou T, Meltzer SJ,. Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer. Virchows Arch 2002; 440: 160-5. (Pubitemid 34169853)
23. Marsit CJ, Zheng S, Aldape K, Hinds PW, Nelson HH, Wiencke JK, Kelsey KT,. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol 2005; 36: 768-76. (Pubitemid 41112032)
24. Wiencke JK, Zheng S, Jelluma N, Tihan T, Vandenberg S, Tamgüney T, Baumber R, Parsons R, Lamborn KR, Berger MS, Wrensch MR, Haas-Kogan DA, et al. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol 2007; 9: 271-9. (Pubitemid 47169659)
25. Kim J, Kim MA, Jee CD, Jung EJ, Kim WH,. Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma. Int J Cancer 2009; 125: 1842-50.
26. Smith LT, Otterson GA, Plass C,. Unraveling the epigenetic code of cancer for therapy. Trends Genet 2007; 23: 449-56. (Pubitemid 47259577)
27. Ushijima T,. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005; 5: 223-31. (Pubitemid 40314953)